Molecular Characterization and Antimicrobial Resistance of Pathogens Isolated from Animals
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics in Animal Health".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 964
Special Issue Editor
2. Biochemistry and Molecular Biology, University of La Rioja, Logrono, Spain
3. Laboratory Associated for Green Chemistry (LAQV-REQUIMTE), New University of Lisbon, Monte da Caparica, Portugal
Interests: antibiotic resistance; genetics; Enterobacteriaceae; microbiology; One Health; Maldi-TOF
Special Issue Information
Dear Colleagues,
Antibiotic resistance is considered a significant public health concern, caused by the use, overuse, and misuse of these drugs in clinic prescription and veterinary medicine. According to some estimations, around 700,000 human deaths every year worldwide are due to the failure of antibiotic treatments for bacterial infections. It has been predicted that this will increase to 10 million people/year by 2050, which represents more than the current mortality associated with different cancers. In recent decades, various studies have reported this situation in animals (including wildlife and pets), humans, and the environment, focusing on a One Health approach.
With this Special Issue, we are looking to gather together manuscripts related to antimicrobial resistance among animals, and studies performed in any part of the world are welcome. The isolation of pathogens harboring novel mutations and mobile genetic elements associated with extended-spectrum beta-lactams, carbapenems, methicillin, and vancomycin are strongly encouraged.
Prof. Dr. Isabel Carvalho
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotic resistance
- molecular biology
- microbiology
- genomics
- multi-drug resistance
- One Health
- animals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
